Efficacy and Safety of Oxycodone/Naloxone (Targin®) in Persistent Moderate to Severe Low Back Pain Following NSAIDs Treatment

NCT03768466 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
123
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Mundipharma Korea Ltd